The nucleocapsid protein of zoonotic betacoronaviruses is an attractive target for antiviral drug discovery

Life Sci. 2021 Oct 1:282:118754. doi: 10.1016/j.lfs.2020.118754. Epub 2020 Nov 12.

Abstract

Betacoronaviruses are in one genera of coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome-related coronavirus (MERS-CoV), etc. These viruses threaten public health and cause dramatic economic losses. The nucleocapsid (N) protein is a structural protein of betacoronaviruses with multiple functions such as forming viral capsids with viral RNA, interacting with viral membrane protein to form the virus core with RNA, binding to several cellular kinases for signal transductions, etc. In this review, we highlighted the potential of the N protein as a suitable antiviral target from different perspectives, including structure, functions, and antiviral strategies for combatting betacoronaviruses.

Keywords: Antiviral; Betacoronavirus; Coronavirus N; Nucleocapsid protein; Protein-protein interaction.

Publication types

  • Review

MeSH terms

  • Animals
  • Antiviral Agents / chemistry*
  • Antiviral Agents / pharmacology*
  • Betacoronavirus / drug effects*
  • Betacoronavirus / physiology
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy*
  • Coronavirus Nucleocapsid Proteins / antagonists & inhibitors
  • Coronavirus Nucleocapsid Proteins / chemistry
  • Coronavirus Nucleocapsid Proteins / metabolism*
  • Drug Discovery*
  • Host-Pathogen Interactions / drug effects
  • Humans
  • Middle East Respiratory Syndrome Coronavirus / drug effects
  • Models, Molecular
  • Molecular Targeted Therapy
  • Phosphoproteins / antagonists & inhibitors
  • Phosphoproteins / chemistry
  • Phosphoproteins / metabolism
  • Protein Interaction Maps / drug effects
  • SARS-CoV-2 / drug effects

Substances

  • Antiviral Agents
  • Coronavirus Nucleocapsid Proteins
  • Phosphoproteins
  • nucleocapsid phosphoprotein, SARS-CoV-2